Symbols / OM $3.16 -0.63%
OM Chart
About
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 57.86M |
| Enterprise Value | -9.47M | Income | -81.65M | Sales | 119.48M |
| Book/sh | 6.99 | Cash/sh | 9.23 | Dividend Yield | — |
| Payout | 0.00% | Employees | 310 | IPO | — |
| P/E | — | Forward P/E | -1.35 | PEG | — |
| P/S | 0.48 | P/B | 0.45 | P/C | — |
| EV/EBITDA | 0.15 | EV/Sales | -0.08 | Quick Ratio | 5.24 |
| Current Ratio | 6.67 | Debt/Eq | 79.75 | LT Debt/Eq | — |
| EPS (ttm) | -5.37 | EPS next Y | -2.35 | EPS Growth | — |
| Revenue Growth | -2.00% | Earnings | 2026-05-06 | ROA | -15.43% |
| ROE | -106.20% | ROIC | — | Gross Margin | 39.13% |
| Oper. Margin | -61.06% | Profit Margin | -68.34% | Shs Outstand | 18.31M |
| Shs Float | 13.06M | Short Float | 12.24% | Short Ratio | 4.88 |
| Short Interest | — | 52W High | 21.98 | 52W Low | 3.00 |
| Beta | 2.10 | Avg Volume | 840.21K | Volume | 112.30K |
| Target Price | $10.50 | Recom | Strong_buy | Prev Close | $3.18 |
| Price | $3.16 | Change | -0.63% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$10.50
Mean price target
2. Current target
$3.16
Latest analyst target
3. DCF / Fair value
$-20.98
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.16
Low
$7.00
High
$15.00
Mean
$10.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-12 | main | BTIG | Buy → Buy | $15 |
| 2026-01-07 | main | Stifel | Buy → Buy | $8 |
| 2025-12-16 | reit | BTIG | Buy → Buy | $17 |
| 2025-11-11 | main | Stifel | Buy → Buy | $14 |
| 2025-11-11 | main | RBC Capital | Sector Perform → Sector Perform | $17 |
| 2025-11-11 | main | BTIG | Buy → Buy | $17 |
| 2025-08-19 | reit | RBC Capital | Sector Perform → Sector Perform | $22 |
| 2025-08-07 | main | RBC Capital | Sector Perform → Sector Perform | $22 |
| 2025-05-21 | main | RBC Capital | Sector Perform → Sector Perform | $21 |
| 2025-05-08 | main | RBC Capital | Sector Perform → Sector Perform | $14 |
| 2025-01-07 | reit | RBC Capital | Sector Perform → Sector Perform | $3 |
| 2024-08-08 | down | RBC Capital | Outperform → Sector Perform | $3 |
| 2024-08-08 | main | TD Cowen | Buy → Buy | $3 |
| 2024-06-21 | up | RBC Capital | Sector Perform → Outperform | $6 |
| 2024-04-08 | init | BTIG | — → Buy | $6 |
| 2024-01-12 | down | RBC Capital | Outperform → Sector Perform | $6 |
| 2023-12-04 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $6 |
| 2023-11-14 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $5 |
| 2023-10-13 | main | RBC Capital | Outperform → Outperform | $17 |
| 2023-10-13 | main | Stifel | Buy → Buy | $6 |
News
RSS: Latest OM news- US stock markets close on high after Iran war drove oil prices above $100 a barrel - The Guardian Sun, 08 Mar 2026 22
- Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Yahoo Finance ue, 13 Jan 2026 08
- Outset Medical stock is down on Q3 sales miss, slashed guidance - MassDevice ue, 11 Nov 2025 08
- $OM stock is up 11% today. Here's what we see in our data. - Quiver Quantitative ue, 27 Jan 2026 08
- AstraZeneca begins trading on the New York Stock Exchange - AstraZeneca Mon, 02 Feb 2026 08
- Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat hu, 19 Feb 2026 08
- FDA clears first dialysis system built to its toughest cybersecurity rules - Stock Titan ue, 27 Jan 2026 08
- Would You Still Hold Outset Medical Stock If It Fell Another 30%? - Trefis Mon, 22 Dec 2025 08
- Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Finviz Fri, 20 Feb 2026 08
- The 10 Best Companies to Invest in Now - Morningstar Mon, 23 Feb 2026 08
- Outset Medical, Inc. (OM) Stock Analysis: Exploring A 139.80% Potential Upside - DirectorsTalk Interviews hu, 05 Feb 2026 08
- Outset Medical (OM): Assessing Valuation After Q3 Miss, Sales Leadership Exit, and Steep Stock Drop - Yahoo Finance Wed, 12 Nov 2025 08
- $OM stock is down 48% today. Here's what we see in our data. - Quiver Quantitative ue, 11 Nov 2025 08
- Dialysis device maker Outset Medical sets Feb. 11 results call - Stock Titan Mon, 26 Jan 2026 08
- OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Yahoo Finance Wed, 28 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3361 | 11259.0 | — | Sale at price 3.35 per share. | TRIGG LESLIE L | Chief Executive Officer | — | 2026-02-17 00:00:00 | D |
| 1 | 2842 | 9521.0 | — | Sale at price 3.35 per share. | BROTTEM JOHN L. | General Counsel | — | 2026-02-17 00:00:00 | D |
| 2 | 1817 | 6087.0 | — | Sale at price 3.35 per share. | NASH MARC | Officer | — | 2026-02-17 00:00:00 | D |
| 3 | 13914 | 71091.0 | — | Sale at price 5.05 - 5.12 per share. | TRIGG LESLIE L | Chief Executive Officer | — | 2026-01-21 00:00:00 | D |
| 4 | 10494 | 53599.0 | — | Sale at price 5.01 - 5.12 per share. | BROTTEM JOHN L. | General Counsel | — | 2026-01-21 00:00:00 | D |
| 5 | 6355 | 32400.0 | — | Sale at price 4.98 - 5.12 per share. | NASH MARC | Officer | — | 2026-01-21 00:00:00 | D |
| 6 | 18667 | — | — | Stock Award(Grant) at price 0.00 per share. | PRANGE KAREN N. | Director | — | 2026-01-09 00:00:00 | D |
| 7 | 1795 | 7665.0 | — | Sale at price 4.27 per share. | TRIGG LESLIE L | Chief Executive Officer | — | 2026-01-07 00:00:00 | D |
| 8 | 224 | 956.0 | — | Sale at price 4.27 per share. | BROTTEM JOHN L. | General Counsel | — | 2026-01-07 00:00:00 | D |
| 9 | 108 | 461.0 | — | Sale at price 4.27 per share. | NASH MARC | Officer | — | 2026-01-07 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.61M | 0.00 | 0.00 | -287.07K |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.21 |
| NormalizedEBITDA | -54.96M | -97.89M | -153.79M | -152.56M |
| TotalUnusualItems | -7.68M | 0.00 | 0.00 | -1.37M |
| TotalUnusualItemsExcludingGoodwill | -7.68M | 0.00 | 0.00 | -1.37M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -81.65M | -127.98M | -172.80M | -162.96M |
| ReconciledDepreciation | 4.34M | 5.73M | 5.81M | 5.17M |
| ReconciledCostOfRevenue | 72.72M | 75.12M | 101.38M | 97.54M |
| EBITDA | -62.64M | -97.89M | -153.79M | -153.93M |
| EBIT | -66.98M | -103.61M | -159.60M | -159.09M |
| NetInterestIncome | -6.54M | -14.11M | -2.50M | -275.00K |
| InterestExpense | 13.95M | 23.87M | 12.68M | 3.57M |
| InterestIncome | 7.41M | 9.76M | 10.17M | 3.29M |
| NormalizedIncome | -75.58M | -127.98M | -172.80M | -161.88M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -81.65M | -127.98M | -172.80M | -162.96M |
| TotalExpenses | 186.18M | 227.06M | 300.15M | 276.39M |
| TotalOperatingIncomeAsReported | -66.71M | -113.38M | -169.77M | -161.02M |
| DilutedAverageShares | 15.21M | 3.46M | 3.31M | 3.21M |
| BasicAverageShares | 15.21M | 3.46M | 3.31M | 3.21M |
| DilutedEPS | -5.37 | -36.90 | -52.20 | -50.70 |
| BasicEPS | -5.37 | -36.90 | -52.20 | -50.70 |
| DilutedNIAvailtoComStockholders | -81.65M | -127.98M | -172.80M | -162.96M |
| NetIncomeCommonStockholders | -81.65M | -127.98M | -172.80M | -162.96M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| NetIncome | -81.65M | -127.98M | -172.80M | -162.96M |
| NetIncomeIncludingNoncontrollingInterests | -81.65M | -127.98M | -172.80M | -162.96M |
| NetIncomeContinuousOperations | -81.65M | -127.98M | -172.80M | -162.96M |
| TaxProvision | 718.00K | 491.00K | 523.00K | 295.00K |
| PretaxIncome | -80.94M | -127.48M | -172.27M | -162.66M |
| OtherIncomeExpense | -7.68M | -1.37M | ||
| SpecialIncomeCharges | -7.68M | 0.00 | 0.00 | -1.37M |
| OtherSpecialCharges | 7.68M | 1.37M | ||
| NetNonOperatingInterestIncomeExpense | -6.54M | -14.11M | -2.50M | -275.00K |
| InterestExpenseNonOperating | 13.95M | 23.87M | 12.68M | 3.57M |
| InterestIncomeNonOperating | 7.41M | 9.76M | 10.17M | 3.29M |
| OperatingIncome | -66.71M | -113.38M | -169.77M | -161.02M |
| OperatingExpense | 113.46M | 151.94M | 198.77M | 178.85M |
| ResearchAndDevelopment | 21.23M | 38.40M | 57.31M | 48.85M |
| SellingGeneralAndAdministration | 92.22M | 113.54M | 141.46M | 130.00M |
| SellingAndMarketingExpense | 54.36M | 70.04M | 96.23M | 89.48M |
| GeneralAndAdministrativeExpense | 37.86M | 43.50M | 45.23M | 40.52M |
| OtherGandA | 37.86M | 43.50M | 45.23M | 40.52M |
| GrossProfit | 46.75M | 38.56M | 29.00M | 17.83M |
| CostOfRevenue | 72.72M | 75.12M | 101.38M | 97.54M |
| TotalRevenue | 119.48M | 113.69M | 130.38M | 115.38M |
| OperatingRevenue | 119.48M | 113.69M | 130.38M | 115.38M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 18.17M | 3.53M | 3.35M | 3.23M |
| ShareIssued | 18.17M | 3.53M | 3.35M | 3.23M |
| NetDebt | 61.23M | 73.36M | 61.60M | 23.11M |
| TotalDebt | 101.25M | 201.86M | 136.19M | 103.23M |
| TangibleBookValue | 126.95M | 26.82M | 122.89M | 245.99M |
| InvestedCapital | 223.19M | 224.19M | 253.00M | 342.33M |
| WorkingCapital | 213.25M | 212.84M | 235.90M | 321.70M |
| NetTangibleAssets | 126.95M | 26.82M | 122.89M | 245.99M |
| CapitalLeaseObligations | 5.01M | 4.48M | 6.08M | 6.89M |
| CommonStockEquity | 126.95M | 26.82M | 122.89M | 245.99M |
| TotalCapitalization | 223.19M | 224.19M | 253.00M | 342.33M |
| TotalEquityGrossMinorityInterest | 126.95M | 26.82M | 122.89M | 245.99M |
| StockholdersEquity | 126.95M | 26.82M | 122.89M | 245.99M |
| GainsLossesNotAffectingRetainedEarnings | 172.00K | 42.00K | 68.00K | -564.00K |
| OtherEquityAdjustments | 172.00K | 42.00K | 68.00K | -564.00K |
| RetainedEarnings | -1.17B | -1.09B | -961.75M | -788.95M |
| AdditionalPaidInCapital | 1.30B | 1.12B | 1.08B | 1.04B |
| CapitalStock | 18.00K | 4.00K | 50.00K | 48.00K |
| CommonStock | 18.00K | 4.00K | 50.00K | 48.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 137.54M | 248.98M | 190.91M | 154.12M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 99.91M | 203.60M | 135.59M | 102.18M |
| NonCurrentAccruedExpenses | 0.00 | 2.69M | 896.00K | 113.00K |
| NonCurrentDeferredLiabilities | 406.00K | 844.00K | 101.00K | 151.00K |
| NonCurrentDeferredRevenue | 406.00K | 844.00K | 101.00K | 151.00K |
| LongTermDebtAndCapitalLeaseObligation | 99.51M | 200.06M | 134.59M | 101.91M |
| LongTermCapitalLeaseObligation | 3.27M | 2.68M | 4.48M | 5.58M |
| LongTermDebt | 96.24M | 197.38M | 130.11M | 96.34M |
| CurrentLiabilities | 37.63M | 45.38M | 55.32M | 51.95M |
| OtherCurrentLiabilities | 4.07M | 3.09M | 5.76M | 7.11M |
| CurrentDeferredLiabilities | 13.79M | 12.75M | 11.73M | 8.66M |
| CurrentDeferredRevenue | 13.79M | 12.75M | 11.73M | 8.66M |
| CurrentDebtAndCapitalLeaseObligation | 1.74M | 1.80M | 1.59M | 1.32M |
| CurrentCapitalLeaseObligation | 1.74M | 1.80M | 1.59M | 1.32M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 10.73M | 16.82M | 19.00M | 21.52M |
| CurrentProvisions | 3.70M | |||
| PayablesAndAccruedExpenses | 7.29M | 10.91M | 17.24M | 13.34M |
| CurrentAccruedExpenses | 6.74M | 7.05M | 11.41M | 12.74M |
| Payables | 554.00K | 3.86M | 5.83M | 603.00K |
| AccountsPayable | 554.00K | 3.86M | 5.83M | 603.00K |
| TotalAssets | 264.50M | 275.80M | 313.80M | 400.12M |
| TotalNonCurrentAssets | 13.61M | 17.57M | 22.58M | 26.47M |
| OtherNonCurrentAssets | 4.15M | 5.50M | 3.93M | 4.48M |
| NetPPE | 9.47M | 12.07M | 18.65M | 21.99M |
| AccumulatedDepreciation | -24.90M | -21.02M | -16.37M | -10.81M |
| GrossPPE | 34.37M | 33.10M | 35.02M | 32.80M |
| Leases | 9.58M | 9.69M | 9.62M | 5.04M |
| ConstructionInProgress | 523.00K | 637.00K | 769.00K | 4.77M |
| OtherProperties | 4.80M | 4.18M | 5.90M | 6.83M |
| MachineryFurnitureEquipment | 19.47M | 18.60M | 18.73M | 16.16M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 250.88M | 258.22M | 291.22M | 373.64M |
| OtherCurrentAssets | 6.00M | 4.53M | 5.70M | 6.60M |
| PrepaidAssets | 5.53M | |||
| Inventory | 47.61M | 59.39M | 49.22M | 51.48M |
| FinishedGoods | 13.11M | 23.71M | 21.78M | 21.77M |
| WorkInProcess | 7.32M | 9.97M | 8.73M | 9.09M |
| RawMaterials | 27.18M | 25.70M | 18.71M | 20.62M |
| Receivables | 28.33M | 35.62M | 32.98M | 28.07M |
| AccountsReceivable | 28.33M | 35.62M | 32.98M | 28.07M |
| CashCashEquivalentsAndShortTermInvestments | 168.95M | 158.69M | 203.32M | 287.50M |
| OtherShortTermInvestments | 133.94M | 34.67M | 134.81M | 214.28M |
| CashAndCashEquivalents | 35.01M | 124.01M | 68.51M | 73.22M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -47.12M | -117.22M | -134.81M | -154.05M |
| RepaymentOfDebt | -204.95M | 0.00 | 0.00 | -31.20M |
| IssuanceOfDebt | 98.27M | 66.52M | 33.23M | 96.06M |
| IssuanceOfCapitalStock | 161.55M | 0.00 | 0.00 | 0.00 |
| CapitalExpenditure | -798.00K | -912.00K | -3.44M | -8.32M |
| InterestPaidSupplementalData | 15.63M | 20.68M | 10.85M | 3.19M |
| IncomeTaxPaidSupplementalData | 447.00K | 593.00K | 491.00K | 385.00K |
| EndCashPosition | 38.84M | 127.34M | 71.84M | 76.53M |
| BeginningCashPosition | 127.34M | 71.84M | 76.53M | 215.66M |
| ChangesInCash | -88.51M | 55.51M | -4.70M | -139.13M |
| FinancingCashFlow | 55.50M | 67.87M | 43.65M | 72.90M |
| CashFlowFromContinuingFinancingActivities | 55.50M | 67.87M | 43.65M | 72.90M |
| NetOtherFinancingCharges | -938.00K | |||
| ProceedsFromStockOptionExercised | 639.00K | 2.28M | 10.43M | 8.04M |
| NetPreferredStockIssuance | 161.55M | 0.00 | 0.00 | 0.00 |
| PreferredStockIssuance | 161.55M | 0.00 | 0.00 | 0.00 |
| NetCommonStockIssuance | 0.00 | 0.00 | 149.09M | |
| CommonStockIssuance | 0.00 | 0.00 | 149.09M | |
| NetIssuancePaymentsOfDebt | -106.68M | 66.52M | 33.23M | 64.86M |
| NetLongTermDebtIssuance | -106.68M | 66.52M | 33.23M | 64.86M |
| LongTermDebtPayments | -204.95M | 0.00 | 0.00 | -31.20M |
| LongTermDebtIssuance | 98.27M | 66.52M | 33.23M | 96.06M |
| InvestingCashFlow | -97.68M | 103.94M | 83.03M | -66.30M |
| CashFlowFromContinuingInvestingActivities | -97.68M | 103.94M | 83.03M | -66.30M |
| NetInvestmentPurchaseAndSale | -96.89M | 104.85M | 86.47M | -57.97M |
| SaleOfInvestment | 125.08M | 261.43M | 258.75M | 203.18M |
| PurchaseOfInvestment | -221.97M | -156.58M | -172.28M | -261.15M |
| NetPPEPurchaseAndSale | -798.00K | -912.00K | -3.44M | -8.32M |
| PurchaseOfPPE | -798.00K | -912.00K | -3.44M | -8.32M |
| OperatingCashFlow | -46.33M | -116.30M | -131.37M | -145.73M |
| CashFlowFromContinuingOperatingActivities | -46.33M | -116.30M | -131.37M | -145.73M |
| ChangeInWorkingCapital | 2.20M | -25.69M | -773.00K | -21.14M |
| ChangeInOtherWorkingCapital | 604.00K | 1.77M | 3.02M | 2.16M |
| ChangeInOtherCurrentLiabilities | -1.91M | -1.59M | -1.35M | -1.15M |
| ChangeInPayablesAndAccruedExpense | -11.12M | -10.78M | 267.00K | -3.70M |
| ChangeInAccruedExpense | -7.83M | -8.83M | -5.04M | -2.42M |
| ChangeInInterestPayable | -2.69M | 0.00 | 0.00 | -721.00K |
| ChangeInPayable | -3.29M | -1.95M | 5.31M | -1.28M |
| ChangeInAccountPayable | -3.29M | -1.95M | 5.31M | -1.28M |
| ChangeInPrepaidAssets | -940.00K | 784.00K | 739.00K | -1.22M |
| ChangeInInventory | 11.79M | -10.86M | 1.65M | -14.73M |
| ChangeInReceivables | 3.77M | -5.01M | -5.09M | -2.51M |
| ChangesInAccountReceivables | 3.77M | -5.01M | -5.09M | -2.51M |
| OtherNonCashItems | 4.34M | 4.01M | 3.10M | 1.50M |
| StockBasedCompensation | 15.62M | 29.36M | 38.63M | 27.20M |
| ProvisionandWriteOffofAssets | 3.39M | 2.94M | 917.00K | 2.65M |
| AmortizationOfSecurities | -2.25M | -4.72M | -6.37M | 449.00K |
| DepreciationAmortizationDepletion | 4.34M | 5.73M | 5.81M | 5.17M |
| DepreciationAndAmortization | 4.34M | 5.73M | 5.81M | 5.17M |
| Depreciation | 5.16M | |||
| OperatingGainsLosses | 7.69M | 53.00K | 106.00K | 1.41M |
| GainLossOnSaleOfPPE | 5.00K | 53.00K | 106.00K | 39.00K |
| NetIncomeFromContinuingOperations | -81.65M | -127.98M | -172.80M | -162.96M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for OM
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|